Cobalis Corp. is a specialty pharmaceutical development company specializing in medications to prevent and treat atopic disease, including allergies, migraine headache, atopic asthma and dermatitis. Its flagship product, PreHistin(TM) - The World's First Pre-Histamine(TM) - is an allergy prevention medication that successfully completed its initial large-scale Phase III Clinical Trial in October of 2005. Upon successful completion of a second FDA-required Phase III Clinical Trial, Cobalis will seek FDA approval to market PreHistin(TM) over-the-counter in the US. Cobalis plans to commence international marketing of PreHistin in late calendar 2006 or 2007.
| Website | http://www.cobalis.com |
| Revenue | $11.8 million |
| Employees | View employees |
| Founded | 2000 |
| Address | 16795 Von Karman Ste 200, Irvine, California 92606, US |
| Phone | +1 949-260-9007 |
| Industry | Manufacturing General, Health Care, Manufacturing, Medical, Pharmaceutical |
| Competitors | Acerus Pharma, Peregrine Pharmaceuticals, BioDelivery Sciences International, MediWound Ltd., Lilly India, Regeneron, Amgen, Bristol Myers Squibb, Viela Bio, Novartis +32 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Cobalis Corp employee's phone or email?
Cobalis Corp Questions
The Cobalis Corp annual revenue was $11.8 million in 2026.
Cobalis Corp is based in Irvine, California.
The NAICS codes for Cobalis Corp are [3254, 32541, 325, 32].
The SIC codes for Cobalis Corp are [28, 283].
